A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC
Clinical trial NCT02981108 · UNKNOWN
Trial details
- NCT number
- NCT02981108
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-08
- Primary completion
- 2019-01-05
- Enrollment
- 364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.